Connective tissue growth factor (CTGF) is a member of the CCN (Cyr 61, CTGF, Nov) family of secreted proteins that functions in various biological processes including embryogenesis. CTGF null mutants die at birth due to defects in lung and bone development. In the developing pancreas, CTGF is expressed in the blood vessel endothelium, ductal epithelium and insulin-producing beta cells. CTGF mutant embryos showed an increased differentiation of glucagon-positive cells beginning at e13.5 and decreased beta cell proliferation at e18.5. CTGF transgenic mouse embryos in which CTGF is over-expressed under the collagen-1 promoter showed an increase in endocrine mass with a decrease in exocrine mass. Based on these findings we hypothesize that CTGF functions in endocrine cell specification and beta cell proliferation. We are generating endocrine-specific doxycycline-inducible bigenic mice to study the effect of CTGF over-expression on endocrine differentiation and beta cell proliferation at different stages of development and in adults. Although CTGF is expressed in beta cells during development it is no longer expressed in adult islets. However, CTGF is re-expressed in the islets of pregnant females. During pregnancy islets are known to undergo adaptive changes including enhanced glucose-stimulated insulin secretion and beta cell proliferation. Preliminary studies with CTGF heterozygous females showed glucose intolerance during pregnancy suggesting a role in beta cell function and/or beta cell mass expansion. Endocrine-specific CTGF null mice, will be used to study the effect of CTGF on islet function during pregnancy. Bones and cartilages that make up craniofacial structures, such as the jaw, are formed by neural crest cells that have migrated to the pharyngeal arches early in craniofacial development. These cells receive many patterning cues from surrounding cells of the pharyngeal ectoderm, mesoderm, and endoderm, leading to the formation of correct skeletal structures. Genetic studies on zebrafish mutants with anterior arch defects revealed that Endothelin-1 (Edn1) is required for the development of ventral craniofacial structures. Loss of edn1 through mutation or morpholino-mediated knockdown results in severe reduction of ventral cartilage components, possibly through decreased cell proliferation or increased cell death of neural crest-derived cells in the pharyngeal arches. Exogenous EDN1 has been shown to increase cell proliferation and decrease cell death in cancer cell lines. Here, we reveal through BrdU labeling that Edn1 functions to promote cell proliferation during early pharyngeal arch development in a spatio-temporal manner. Edn1-dependent cell proliferation may be limited to early pharyngeal arch development as the effect of edn1 loss is stronger at earlier stages in edn1 MO treated zebrafish embryos. In addition, Edn1 functions as a survival factor, as loss of edn1 leads to increased cell death detected by TUNEL staining during early pharyngeal arch development. From these results, we conclude that edn1 patterns ventral skeleton by controlling cell proliferation and cell death of the neural crest-derived cells early in pharyngeal arch development. (Supported by NIH grant F32 DE0190565-01A1).
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